title: Traveling a long and winding road toward personalized medicine.
abstract: To a third-party payer, perhaps the most interesting activity at this year's Biotechnology Industry Organization convention was not the din from the array of manufacturers and the states and countries hoping to land their business, but the sessions that addressed the viability of the biotech pipeline and its potential for providing competitive products. In Chicago, our man at BIO talked with the principals and reports on what they are saying.
authors: John
authors: J
authors: Otrompke